Search - tctmd.com

Displaying 121 - 140 of 160

Sort: Relevancy | Date

Presentation TCT 2018

Device Selection and CT Sizing for TAVR Treatment of BAV

Presenter: Joseph E. Bavaria, Horst Sievert, Lars Sondergaard

September 22, 2018

Presentation TCT 2018

The Voice of Reason: Why a Randomized Trial is Necessary to Decide if Surgery or TAVR are Preferred in BAV Patients!

Presenter: Joseph E. Bavaria, Horst Sievert, Hasan Jilaihawi

September 22, 2018

Presentation TCT 2018

A Structural Interventionalist Perspective on BAV Treatment: The Next TAVR Frontier Almost All Patients are TAVR Candidates

Presenter: Joseph E. Bavaria, Horst Sievert, Mathew Williams

September 22, 2018

Presentation TCT 2018

A CT Imaging Perspective on BAV Treatment: Which Patients are Poor Candidates for TAVR

Presenter: Joseph E. Bavaria, Horst Sievert, Jonathon A. Leipsic

September 22, 2018

Presentation TCT 2018

A Surgeons Perspective on BAV Treatment: Why Surgery is Preferred in Many (Most) BAV Patients

Presenter: Joseph E. Bavaria, Horst Sievert

September 22, 2018

Presentation TCT 2017

TAVR Outcomes for Bicuspid Aortic Valve Disease in Asian Patients

Presenter: Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Practical Tips for TAVR in Bicuspid Aortic Valves: Device Selection, Valve Sizing and Positioning

Presenter: Didier Tchetche

November 01, 2017

Presentation TCT 2017

Outcomes after TAVR in Bicuspid vs Tricuspid Aortic Valves: Results From a Multicenter Study with Propensity Matching

Presenter: Raj Makkar

November 01, 2017

Presentation TCT 2017

Revised Classification of Bicuspid Aortic Valve Disease Based on CT-Imaging: Implications for TAVR Therapy

Presenter: Hasan Jilaihawi

November 01, 2017

Presentation TCT 2017

Flash Debate: Surgery Remains the First Option in All Operable Patients With Bicuspid Aortic Stenosis!

Presenter: Gilles Dreyfus, Sanjay Kaul, Alfredo Trento

November 01, 2017

Presentation TCT 2017

Flash Debate: Enough Evidence Is Present to Justify TAVR in Select Patients With Bicuspid Aortic Stenosis!

Presenter: Gilles Dreyfus, Sanjay Kaul, John G. Webb

November 01, 2017

Presentation TCT 2017

TAVR for Severe AS Due to Bicuspid Aortic Valve Disease

Presenter: Gregory P. Fontana, Alexander Lauten

November 01, 2017

Presentation TCT 2017

The Venus A and Venibri TAVR Systems Better for Bicuspids and Dry Leaflet Technology

Presenter: Jeffrey J. Popma, John G. Webb, Horst Sievert

October 31, 2017

Presentation TCT 2017

FYRM Macedonia Presents: Minimalistic Approach for TAVR in Bicuspid Aortic Valve After Liver Transplant

Presenter: Emmanouil I Skalidis, Sasko Kedev

October 31, 2017

Presentation TCT 2017

TAVR should be reserved for intermediate and higher-risk tricuspid valve aortic stenosis!

Presenter: A. Pieter Kappetein

October 30, 2017

Presentation TCT 2017

Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

Presenter: Susheel K. Kodali

October 30, 2017

Presentation TCT 2017

Technical Approach to Bicuspid Aortic Valves

Presenter: Martin B. Leon, Yongjian Wu, Zhen-Gang Zhao

October 29, 2017

Presentation TCT 2017

Case Presentation: TAVR in Bicuspid Aortic Stenosis With Severe Calcification

Presenter: Martin B. Leon, Yongjian Wu, Jun Jiang

October 29, 2017

News Conference News TCT 2016

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Yael L. Maxwell

November 02, 2016

Presentation TCT 2016

FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways

Presenter: Nicole Ibrahim, Martin B. Leon, Jaime Raben

November 01, 2016

Advertisement

Device Selection and CT Sizing for TAVR Treatment of BAV

The Voice of Reason: Why a Randomized Trial is Necessary to Decide if Surgery or TAVR are Preferred in BAV Patients!

A Structural Interventionalist Perspective on BAV Treatment: The Next TAVR Frontier Almost All Patients are TAVR Candidates

A CT Imaging Perspective on BAV Treatment: Which Patients are Poor Candidates for TAVR

A Surgeons Perspective on BAV Treatment: Why Surgery is Preferred in Many (Most) BAV Patients

TAVR Outcomes for Bicuspid Aortic Valve Disease in Asian Patients

Practical Tips for TAVR in Bicuspid Aortic Valves: Device Selection, Valve Sizing and Positioning

Outcomes after TAVR in Bicuspid vs Tricuspid Aortic Valves: Results From a Multicenter Study with Propensity Matching

Revised Classification of Bicuspid Aortic Valve Disease Based on CT-Imaging: Implications for TAVR Therapy

Flash Debate: Surgery Remains the First Option in All Operable Patients With Bicuspid Aortic Stenosis!

Flash Debate: Enough Evidence Is Present to Justify TAVR in Select Patients With Bicuspid Aortic Stenosis!

TAVR for Severe AS Due to Bicuspid Aortic Valve Disease

The Venus A and Venibri TAVR Systems Better for Bicuspids and Dry Leaflet Technology

FYRM Macedonia Presents: Minimalistic Approach for TAVR in Bicuspid Aortic Valve After Liver Transplant

TAVR should be reserved for intermediate and higher-risk tricuspid valve aortic stenosis!

Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

Technical Approach to Bicuspid Aortic Valves

Case Presentation: TAVR in Bicuspid Aortic Stenosis With Severe Calcification

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content